Additionally, integrating ChIP-seq and RNA-seq analyses to systematically identify downstream targets and signaling pathways regulated by RFX1 will provide further insights into its mechanistic role in tumor-immune interactions and immune evasion. The gene discussed is RFX1; the disease is neoplasm.